Moderate riskFDA DrugClass II

Sun Pharma sumatriptan-naproxen tablets recalled, failed dissolution

Sun Pharmaceutical Industries is recalling one lot of Sumatriptan and Naproxen Sodium Tablets, 85 mg/500 mg, in 9-count bottles. A 12-month stability test found results outside the dissolution specifications. Dissolution testing measures how the tablet breaks down and releases its medicine.

From the FDA notice · Read the official notice ↗ · All Sun Pharmaceutical recalls

What to do

  1. Talk to your pharmacist or prescriber before stopping this medicine.
  2. Check the bottle for NDC 47335-410-22 and lot DNG0559B, expiring 5/31/2027.
  3. The notice doesn't say how to get a refund or replacement; contact Sun Pharma or the pharmacy where you bought it.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Sumatriptan and Naproxen Sodium Tablets, 85mg/500mg,9-count bottle, Rx only, SUN PHARMA, NDC 47335-410-22.
Sold in
Nationwide
Made for
Adults (0 months and older)

This recall covers 2 products — see all of them.

Details

Units affected
10,296 bottles
Illnesses reported
None reported
Manufactured in
2 Independence Way, Princeton, New Jersey, United States
Classification
Class II
Recall number
D-0186-2027

In the FDA's words

Description
Sumatriptan and Naproxen Sodium Tablets, 85mg/500mg,9-count bottle, Rx only, SUN PHARMA, NDC 47335-410-22. Failed Dissolution Specifications: (OOS) results was observed for dissolution Test during the analysis performed at the 12month Stability Lot: Lot DNG0559B, Expires: 5/31/2027 Distribution: Nationwide within the U.S Affected quantity: 10,296 bottles
Hazard
Failed Dissolution Specifications: (OOS) results was observed for dissolution Test during the analysis performed at the 12month Stability

2 products in this recall

Sun Pharma and Northstar sumatriptan-naproxen tablets recalled for dissolution failure

Sun Pharmaceutical is recalling 2 products of sumatriptan and naproxen sodium tablets, 85mg/500mg, in 9-count bottles, sold under the SUN PHARMA label and by Northstar Healthcare Holdings Ltd. Testing at the 12-month stability point found results that failed the tablets' dissolution specifications. The recall covers about 13,700 bottles distributed nationwide.

The agency lists each product separately. Check every one you might have.

More from Sun Pharmaceutical

See all

Related topics

PotencyDrugsSold nationwideMore from FDA Drug